ESTA
Establishment Labs Holdings Inc. NASDAQ Listed Jul 19, 2018$72.03
After hrs
$71.77
+0.00%
Mkt Cap $2.1B
52w Low $33.30
77.4% of range
52w High $83.31
50d MA $65.47
200d MA $58.26
P/E (TTM)
-40.8x
EV/EBITDA
-71.7x
P/B
88.3x
Debt/Equity
11.2x
ROE
-216.9%
P/FCF
-37.9x
RSI (14)
—
ATR (14)
—
Beta
1.08
50d MA
$65.47
200d MA
$58.26
Avg Volume
496.9K
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Building B15 and 25 · Alajuela, G2 20101 · CR
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | BMO | -0.21 | -0.09 | +58.1% | 79.67 | +0.3% | -1.7% | -3.2% | -1.2% | -4.5% | -10.7% | — |
| Nov 5, 2025 | BMO | -0.54 | -0.38 | +29.6% | 60.51 | +1.6% | +7.3% | +7.4% | +11.9% | +13.1% | +4.4% | — |
| Aug 7, 2025 | BMO | -0.54 | -0.57 | -5.6% | 35.96 | -0.3% | -3.2% | -6.5% | -6.5% | +6.6% | +5.5% | — |
| May 7, 2025 | BMO | -0.83 | -0.70 | +15.7% | 33.27 | +4.4% | +4.6% | +2.0% | +3.9% | +5.1% | +9.6% | — |
| Feb 26, 2025 | BMO | -0.64 | -0.98 | -53.1% | 36.06 | +5.4% | +17.9% | +18.9% | +18.9% | +28.1% | +20.9% | — |
| Nov 7, 2024 | BMO | -0.61 | -0.59 | +3.3% | 48.12 | -11.4% | -3.9% | -5.9% | -11.9% | -18.3% | -22.0% | — |
| Aug 6, 2024 | BMO | -0.51 | -0.62 | -21.6% | 36.53 | -7.8% | -2.7% | +6.7% | +13.6% | +12.3% | +16.0% | — |
| May 8, 2024 | BMO | -0.67 | -0.58 | +13.4% | 51.25 | +6.1% | +10.9% | +9.2% | +9.6% | +14.8% | +16.8% | — |
| Feb 28, 2024 | BMO | -0.91 | -0.79 | +13.2% | 38.46 | +19.6% | +18.8% | +14.7% | +23.4% | +19.7% | +28.1% | — |
| Nov 7, 2023 | BMO | -0.80 | -1.12 | -40.0% | 32.70 | -36.5% | -23.2% | -30.3% | -33.7% | -32.6% | -21.1% | — |
| Aug 8, 2023 | BMO | -0.72 | -0.65 | +9.7% | 61.28 | +1.2% | -5.3% | -7.1% | -9.0% | -7.2% | -8.3% | — |
| May 8, 2023 | BMO | -0.68 | -0.48 | +29.4% | 67.69 | -2.2% | +1.8% | +5.6% | +3.6% | -1.6% | +1.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 | BTIG | Maintains | Buy → Buy | — | $64.40 | $64.12 | -0.4% | -3.1% | +6.6% | +9.1% | +9.1% | +10.2% |
| Mar 11 | Citigroup | Maintains | Neutral → Neutral | — | $66.35 | $66.36 | +0.0% | -0.2% | -4.1% | -4.5% | -4.3% | -2.0% |
| Feb 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $78.29 | $78.00 | -0.4% | -1.5% | +0.5% | -2.8% | -9.2% | -9.1% |
| Feb 25 | Stephens & Co. | Maintains | Overweight → Overweight | — | $79.67 | $79.90 | +0.3% | -1.7% | -3.2% | -1.2% | -4.5% | -10.7% |
| Feb 25 | Mizuho | Maintains | Outperform → Outperform | — | $79.67 | $79.90 | +0.3% | -1.7% | -3.2% | -1.2% | -4.5% | -10.7% |
| Feb 24 | Needham | Maintains | Buy → Buy | — | $74.96 | $66.47 | -11.3% | +6.3% | +4.4% | +2.9% | +5.0% | +1.5% |
| Feb 24 | BTIG | Maintains | Buy → Buy | — | $74.96 | $66.47 | -11.3% | +6.3% | +4.4% | +2.9% | +5.0% | +1.5% |
| Jan 12 | Needham | Maintains | Buy → Buy | — | $68.34 | $71.88 | +5.2% | -2.3% | -4.7% | -3.1% | -3.5% | -1.2% |
| Dec 31 | BTIG | Maintains | Buy → Buy | — | $72.92 | $74.47 | +2.1% | -0.1% | -5.6% | -8.9% | -4.9% | -4.0% |
| Dec 17 | Mizuho | Maintains | Outperform → Outperform | — | $74.15 | $74.10 | -0.1% | +0.8% | -6.1% | +0.4% | +3.3% | +2.7% |
| Dec 17 | Canaccord Genuity | Maintains | Buy → Buy | — | $74.15 | $74.10 | -0.1% | +0.8% | -6.1% | +0.4% | +3.3% | +2.7% |
| Dec 17 | JP Morgan | Maintains | Overweight → Overweight | — | $74.15 | $74.10 | -0.1% | +0.8% | -6.1% | +0.4% | +3.3% | +2.7% |
| Dec 11 | Citigroup | Maintains | Neutral → Neutral | — | $72.46 | $72.98 | +0.7% | +0.4% | +0.1% | -0.6% | +2.3% | +3.1% |
| Dec 10 | Needham | Maintains | Buy → Buy | — | $71.01 | $72.88 | +2.6% | +2.0% | +2.4% | +2.1% | +1.4% | +4.4% |
| Nov 14 | BTIG | Maintains | Buy → Buy | — | $64.75 | $64.06 | -1.1% | -1.2% | +1.7% | -0.3% | +3.2% | +2.0% |
| Nov 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $60.51 | $61.45 | +1.6% | +7.3% | +7.4% | +11.9% | +13.1% | +4.4% |
| Nov 6 | Mizuho | Maintains | Outperform → Outperform | — | $60.51 | $61.45 | +1.6% | +7.3% | +7.4% | +11.9% | +13.1% | +4.4% |
| Nov 6 | Needham | Maintains | Buy → Buy | — | $60.51 | $61.45 | +1.6% | +7.3% | +7.4% | +11.9% | +13.1% | +4.4% |
| Nov 6 | JP Morgan | Maintains | Overweight → Overweight | — | $60.51 | $61.45 | +1.6% | +7.3% | +7.4% | +11.9% | +13.1% | +4.4% |
| Nov 5 | BTIG | Maintains | Buy → Buy | — | $49.40 | $53.91 | +9.1% | +22.5% | +31.4% | +31.6% | +37.0% | +38.6% |
| Jul 16 | Mizuho | Maintains | Outperform → Outperform | — | $44.42 | $45.12 | +1.6% | -1.7% | -4.4% | -6.4% | -4.1% | -2.1% |
| Jul 9 | Citigroup | Maintains | Neutral → Neutral | — | $43.97 | $44.08 | +0.3% | +2.5% | +4.5% | +2.1% | +3.5% | +1.0% |
| Jun 13 | Needham | Maintains | Buy → Buy | — | $37.12 | $36.04 | -2.9% | +0.9% | +4.8% | +0.8% | +2.5% | +1.9% |
| May 14 | Needham | Upgrade | Hold → Buy | — | $34.96 | $36.41 | +4.1% | +4.3% | +4.7% | +3.4% | +5.3% | +7.7% |
| Mar 6 | Stephens & Co. | Maintains | Overweight → Overweight | — | $43.60 | $42.63 | -2.2% | -3.5% | -4.4% | -15.8% | -17.9% | -12.7% |
| Feb 27 | Stephens & Co. | Maintains | Overweight → Overweight | — | $36.06 | $38.00 | +5.4% | +17.9% | +18.9% | +18.9% | +28.1% | +20.9% |
| Oct 14 | BTIG | Maintains | Buy → Buy | — | $39.83 | $40.42 | +1.5% | +3.6% | +6.8% | +7.7% | +6.2% | +5.2% |
| Oct 1 | Citigroup | Maintains | Neutral → Neutral | — | $43.27 | $43.00 | -0.6% | -6.3% | +3.2% | -3.4% | +4.6% | +6.8% |
| Aug 22 | Citigroup | Maintains | Neutral → Neutral | — | $44.05 | $44.40 | +0.8% | -1.6% | +3.6% | +4.6% | +5.0% | +4.9% |
| Aug 7 | JP Morgan | Maintains | Overweight → Overweight | — | $36.53 | $33.69 | -7.8% | -2.7% | +6.7% | +13.6% | +12.3% | +16.0% |
| Aug 7 | Stephens & Co. | Maintains | Overweight → Overweight | — | $36.53 | $33.69 | -7.8% | -2.7% | +6.7% | +13.6% | +12.3% | +16.0% |
| Jul 10 | Citigroup | Maintains | Neutral → Neutral | — | $44.29 | $44.50 | +0.5% | -2.2% | +3.0% | +1.4% | +2.8% | +10.6% |
| Jun 6 | Mizuho | Maintains | Buy → Buy | — | $53.89 | $54.51 | +1.2% | -4.0% | -10.7% | -10.1% | -13.5% | -12.0% |
| May 22 | Citigroup | Downgrade | Buy → Neutral | — | $54.37 | $52.64 | -3.2% | -2.0% | -2.3% | -1.5% | -2.4% | -4.9% |
| Apr 3 | Citigroup | Maintains | Buy → Buy | — | $50.45 | $50.95 | +1.0% | +4.6% | +4.5% | +7.4% | +7.4% | +9.8% |
| Apr 1 | Mizuho | Maintains | Buy → Buy | — | $50.90 | $52.13 | +2.4% | -4.1% | -0.9% | +3.7% | +3.5% | +6.4% |
| Mar 12 | TD Cowen | Maintains | Outperform → Outperform | — | $48.73 | $49.88 | +2.4% | +2.7% | +3.5% | -0.9% | +0.6% | +4.0% |
| Feb 29 | JP Morgan | Maintains | Overweight → Overweight | — | $38.46 | $45.99 | +19.6% | +18.8% | +14.7% | +23.4% | +19.7% | +28.1% |
| Jan 11 | Stephens & Co. | Maintains | Overweight → Overweight | — | $31.68 | $31.51 | -0.5% | +7.6% | +11.9% | +9.6% | +9.2% | +14.0% |
| Nov 9 | B. Riley Securities | Maintains | Buy → Buy | — | $25.11 | $26.50 | +5.5% | -9.3% | -13.7% | -12.2% | +2.8% | -7.3% |
| Nov 8 | Mizuho | Maintains | Buy → Buy | — | $32.70 | $20.75 | -36.5% | -23.2% | -30.3% | -33.7% | -32.6% | -21.1% |
| Nov 8 | TD Cowen | Maintains | Outperform → Outperform | — | $32.70 | $20.75 | -36.5% | -23.2% | -30.3% | -33.7% | -32.6% | -21.1% |
| Jul 21 | Stephens & Co. | Maintains | Overweight → Overweight | — | $68.83 | $69.67 | +1.2% | +2.3% | +1.9% | +0.8% | -0.4% | +2.2% |
| Apr 21 | Mizuho | Maintains | Buy → Buy | — | $74.92 | $75.94 | +1.4% | -0.0% | -2.1% | -3.9% | -5.5% | -8.6% |
| Apr 21 | Stephens & Co. | Maintains | Overweight → Overweight | — | $74.92 | $75.94 | +1.4% | -0.0% | -2.1% | -3.9% | -5.5% | -8.6% |
| Apr 17 | BTIG | Maintains | Buy → Buy | — | $73.27 | $73.99 | +1.0% | +1.9% | +2.3% | +3.6% | +2.3% | +2.2% |
| Feb 28 | Stephens & Co. | Maintains | Overweight → Overweight | — | $67.04 | $68.64 | +2.4% | +6.9% | +8.8% | +4.3% | +9.9% | +11.1% |
| Jan 24 | Mizuho | Maintains | Buy → Buy | — | $68.21 | $68.86 | +1.0% | -1.2% | +0.3% | -1.2% | -3.2% | -1.5% |
| Dec 28 | Stephens & Co. | Maintains | Overweight → Overweight | — | $60.12 | $59.89 | -0.4% | +0.5% | +7.9% | +9.2% | +4.3% | +8.2% |
| Oct 13 | Mizuho | Maintains | Buy → Buy | — | $55.96 | $56.47 | +0.9% | +2.7% | -0.3% | +2.2% | +0.7% | -8.6% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | JW Asset Management, LLC10% | — | Sell | 60,000 | $75.62 | $4.5M | 3,001,694 | — | — |
| May 6, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 11,794 | $76.10 | $898K | 927,504 | — | — |
| May 6, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 93,206 | $75.33 | $7.0M | 939,298 | — | — |
| May 4, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 100 | $71.34 | $7K | 1,032,504 | +1.07% | — |
| May 4, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 7,651 | $70.47 | $539K | 1,032,604 | +1.07% | — |
| May 1, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 25,984 | $71.18 | $1.8M | 1,040,255 | +1.07% | — |
| May 1, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 41,265 | $70.52 | $2.9M | 1,066,239 | +1.07% | — |
| Apr 27, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 165 | $67.14 | $11K | 1,107,504 | -1.63% | +7.29% |
| Apr 27, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 1,008 | $66.46 | $67K | 1,107,669 | -1.63% | +7.29% |
| Apr 27, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 1,007 | $65.91 | $66K | 1,108,677 | -1.63% | +7.29% |
| Apr 24, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 7,568 | $66.13 | $500K | 1,109,684 | -1.63% | +7.29% |
| Apr 24, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 22,610 | $65.66 | $1.5M | 1,117,252 | -1.63% | +7.29% |
| Apr 23, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 400 | $67.36 | $27K | 1,139,862 | -1.63% | +7.29% |
| Apr 23, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 6,757 | $66.20 | $447K | 1,140,262 | -1.63% | +7.29% |
| Apr 23, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 30,549 | $65.33 | $2.0M | 1,147,019 | -1.63% | +7.29% |
| Apr 23, 2026 | Chacon Quiros Juan JoseDir | — | Sell | 4,936 | $64.83 | $320K | 1,177,568 | -1.63% | +7.29% |
8-K · 2.02
!! High
Establishment Labs Holdings Inc. -- 8-K 2.02: Earnings Results
Establishment Labs reported earnings results; investors should review the full press release for detailed financial performance metrics and guidance that may impact the stock's valuation.
May 6
8-K · 1.01
! Medium
Establishment Labs Holdings Inc. -- 8-K 1.01: Financing / Debt Agreement
Establishment Labs secured $259 million in amended credit facilities, strengthening its balance sheet and providing capital for operations and growth initiatives.
Apr 30
8-K
Establishment Labs Holdings Inc. -- 8-K Filing
Establishment Labs reported 2025 financial results and issued 2026 guidance, providing investors with updated performance metrics and forward-looking projections for the medical device company.
Feb 24
Data updated apr 25, 2026 7:46am
· Source: massive.com